Drug overdose deaths fall in 2023 for 1st time since pandemic began: CDC
Rates of drug overdose deaths decreased in the United States for the first time since the COVID-19 pandemic began, according to new federal data published early Thursday.
The rate of overdose deaths fell from 32.6 deaths per 100,000 people in 2022 to 31.3 per 100,000 people in 2023, a 4% decrease, according to the report from the Centers for Disease Control and Prevention's National Center for Health Statistics.
Dr. Aitzaz Munir, an assistant professor of psychiatry at Rutgers New Jersey Medical School and associate program director for the Rutgers Addiction Medicine Fellowship Program, told ABC News the drop in the overdose death rate was "surprising" to him but a positive sign.
MORE: Overdose deaths have continued to drop, now at their lowest level in 3 years, data shows
He said he believes the decrease in deaths may be due to a more "aggressive approach" toward the treatment of drug conditions including more treatment programs and making them more widely available.
This includes making naloxone, an overdose reversal drug, more widely available and increasing the availability of drug checking supplies, including fentanyl test strips.
"So, there might be a better response in places where these treatments are available and patients are getting those treatments," he said. "Treatment for addiction works, and if we are seeing this result that there's a decrease in death rates, that is because of the treatment the patients are getting."
Dr. Magadelna Cerdá, a professor in the department of population health and director of the center for opioid epidemiology and policy at New York University Grossman School of Medicine, said the drop may also be linked to a decrease in the fentanyl supply.
Fentanyl has been associated with an increase in overdose deaths over the last several years. It is up to 50 times more potent than heroin and 100 times more potent than morphine, and can be deadly even in small doses, according to the CDC.
She said the U.S. Drug Enforcement Agency announced last year that the potency of fentanyl pills agents have been seizing was decreasing, which may be contributing to the decline.
"As the drug supply has become more saturated with fentanyl, good drug supply may be becoming more stable, and people may be just developing a tolerance for fentanyl," Cerdá said.
The report found that West Virginia was the state with the highest rate at 81.9 deaths per 100,000 while Nebraska had the lowest rate at 9.0 deaths per 100,000.
Additionally, between 2022 and 2023, rates of drug overdose deaths decreased in 20 states and did not change significantly in 25 states.
MORE: Overdose crisis reaches historic levels in New York City
Meanwhile, over that same period, increases were seen in six states: Alabama, Alaska, California, Nevada, Oregon and Washington.
Cerdá said one hypothesis is that the increase in overdose death rates in western states may be due to shifts in the drug market.
"We saw that the penetration of fentanyl really started in the East Coast," she said. "Over time, we saw a shift in the drug supply where fentanyl actually has started to enter the western drug markets … we also see a recent increase in counterfeit pills containing fentanyl, which has also infiltrated the drug market."
Nationwide, the overdose death rate from any opioid decreased from 25 deaths per 100,000 in 2022 to 24 deaths per 100,000 deaths in 2023. The death rate from synthetic opioids other than methadone -- which includes fentanyl -- fell as well from 22.7 deaths to 22.2 deaths per 100,000.
Meanwhile, the overdose death rate for psychostimulants with abuse potential, which includes methamphetamine, increased from 10.4 deaths per 100,000 in 2022 to 10.6 deaths in 2023. The death rate for cocaine also increased from 8.2 deaths per 100,000 to 8.6 over the same period.
"We should celebrate the decline in overdose deaths, particularly in some of those areas which have historically been most hard hit by this epidemic," Cerdá said. "And we should invest resources and trying to figure out why the decrease is happening, and how can we learn, particularly from those states that are experiencing this decrease to proactively respond to those states which are currently experiencing an increase."
Drug overdose deaths fall in 2023 for 1st time since pandemic began: CDC originally appeared on abcnews.go.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
26 minutes ago
- Axios
Vaccine board purge stokes talk of CDC alternatives
By gutting the expert panel that's advised the government on vaccine policy for more than 60 years, Health Secretary Robert F. Kennedy Jr. earned the condemnation of virtually every medical society, as well as former public health officials and local practitioners. What became immediately clear is that no outside group can immediately step in and fill the vacuum if the public won't trust the reconstituted Advisory Committee on Immunization Practices. The big picture: The distress and lack of organization apparent in health circles on Tuesday was a sign that a new independent body that could act as a "shadow CDC" to truth-squad the Trump administration isn't close to materializing. "We are clearly working on it and we think it's very important, but I don't think anyone has an answer yet," said Michael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy, who's behind one ad hoc effort. "Right now, we're in such uncharted territory." The medical establishment has floated ideas such as state-appointed boards or medical specialty associations serving as clearinghouses for information on vaccine safety and efficacy for clinicians. California Gov. Gavin Newsom (D) during the pandemic created a state entity to review the safety of federally approved COVID-19 vaccines before distributing them to the public. But it would be difficult to replicate the professional clout of ACIP, whose recommendations can influence whether insurers cover vaccines. That would leave Kennedy's handpicked successors controlling the narrative — a prospect many researchers and physicians think will bring a radical departure from ACIP's evidence-based deliberations on safety and efficacy. Friction point: Kennedy and other Trump health officials' assertions that ACIP has been a rubber stamp for vaccines have infuriated public health officials, who say the physicians, infectious disease experts and researchers constituted a vital body of nongovernmental health leaders who took their jobs seriously. Panel members were carefully vetted for conflicts and had their professional credentials scrutinized. Discussions took place in a high-profile public forum that would be difficult, if not impossible, to replicate. "Many of us can provide a read of the science, and we can convene formally or informally to create consensus around vaccine recommendations," said Megan Ranney, dean of the Yale School of Public Health. "But I suspect that it won't be sufficient for insurers, for Medicaid, for the Vaccines for Children program, and it's unclear how pediatricians and primary care physicians and pharmacies across the country are going to be able to respond," she said. The other side: Kennedy wrote on X Tuesday night that he would announce new ACIP members in the coming days. "None of these individuals will be ideological anti-vaxxers. They will be highly credentialed physicians and scientists," Kennedy wrote. He added he would detail instances of "historical corruption at ACIP to help the public understand why this clean sweep was necessary. "Kennedy cited the panel's "stubborn unwillingness to demand adequate safety trials before recommending new vaccines for our children" as the most "outrageous example." What to watch: All eyes are on the new appointees for the board, including their scientific backgrounds, track records when it comes to defending vaccines and any potential conflicts of interest. HHS has indicated it has every intention of moving forward with ACIP's next meeting, scheduled for June 25-27. The agenda includes recommendation votes for COVID–19, HPV, influenza, meningococcal and RSV vaccines. "If nothing else, I think [the committee] may have trouble functioning because you've just lost a whole lot of institutional memory," said Adam Ratner, a member of the American Academy of Pediatrics' Committee on Infectious Diseases. "That agenda has the committee voting on real things that matter to real people, and I don't know how they're possibly going to do that in any kind of way that is based on science or evidence," he said.
Yahoo
2 hours ago
- Yahoo
CDC firings: Former director, fired vaccine panelist on RFK Jr's changes
(NewsNation) — While Health and Human Services Secretary Robert F. Kennedy Jr. says he wanted to restore public trust by firing the entire vaccine advisory panel at the Centers for Disease Control and Prevention, one person he fired says Kennedy did the opposite in the academic community. The Advisory Committee on Immunization Practices members was made up of medical and health professionals who made recommendations on the safety and use of vaccines. One of the 17 panelists fired is Dr. Noel Brewer, who joined NewsNation's 'CUOMO' on Tuesday night. 'My concern is that we've taken 60 years of efforts to build trust among health care providers in the recommendations of the advisory committee through CDC, and that trust just evaporated overnight,' Brewer said. 'It is going to be hard to get that back.' The committee was set to meet in two weeks to discuss COVID-19 and other vaccines. Judge determined OPM broke law with DOGE access to data 'I don't think most Americans even care that much about it. And now that there's all this news and people like me out from our ivory towers, it's generating interest,' Brewer said. 'But I don't think that the impact here is going to be primarily among the general public.' Dr. Robert Redfield was CDC director under the first Trump administration, and he said the public lost trust in the power of vaccines. 'I believe vaccines are the most important gift of science to modern medicine. When I was CDC director, I was very disturbed that over half of the population didn't get the flu vaccine,' he said. 'Then, the COVID pandemic came, and I have to say, although I have a lot of respect for Noel and the other people on the committee, the reality is the guidance that came out of the ACIP for COVID vaccines, I think in general, was ill-advised.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
8 hours ago
- Yahoo
Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul
Former White House COVID-19 response coordinator Ashish Jha, who served under former President Biden, criticized the decision by Health and Human Services Secretary Robert F. Kennedy Jr. to fire all 17 experts on the U.S. Centers for Disease Control and Prevention's (CDC) vaccine panel. Kennedy announced the decision in an op-ed for The Wall Street Journal on Monday, saying, 'A clean sweep is needed to re-establish public confidence in vaccine science.' But in an interview with CNN's Wolf Blitzer, Jha pushed back against Kennedy's reasoning. 'Look, what he said in his op-ed was a series of nonsense about a group of individuals, experts …who shape what vaccines, if any, are going to be available to the American people,' Jha said in the interview. 'So obviously this is very concerning,' he continued. 'We'll have to see who he appoints next. But this is a step in the wrong direction.' Jha said he is concerned about what the move foretells about the secretary's agenda on vaccines. Jha pointed to what he characterized as a lackluster response from the secretary to 'the worst measles outbreak of the last 25 years.' He also expressed concern regarding Kennedy's raising questions about vaccines causing autism, which Jha dismissed and said was 'settled science.' 'Then you put this in the middle of all of that,' Jha said, referring to the vaccine panel sweep, 'and what you have is a pretty clear picture that what Secretary Kennedy is trying to do is make sure that vaccines are not readily available to Americans, not just for kids, for the elderly.' 'He could go pretty far with this move, and I really am worried about where we're headed,' Jha continued. He said he's particularly concerned about the effect Kennedy's move will have on kids and whether they will continue having access to certain vaccines in the future. 'Kids rely on vaccines. I'm worried about whether the next generation of kids are going to have access to polio vaccines and measles vaccines. That's where we're heading. That's what we have to push back against.' Kennedy said in his op-ed that he was removing every member of the panel to give the Trump administration an opportunity to appoint its own members. Kennedy has long accused members of the Advisory Committee on Immunization Practices of having conflicts of interest, sparking concern among vaccine advocates that he would seek to install members who are far more skeptical of approving new vaccines. But Jha pushed back against criticism that the panel was all Biden-appointed experts, saying, 'When the Biden administration came in, almost all of the appointees had come from the first Trump administration.' 'That was fine because they were good people,' he said. 'They were experts. Right now, it's the same thing. The people he is firing are experts — like a nurse in Illinois who spent her entire career getting kids vaccinated, cancer doctors from Memorial Sloan Kettering — like these are really good people.' 'And generally, CDC has not worried about when were they appointed. The question is, are they good and are they conflict free.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
